206 related articles for article (PubMed ID: 21450690)
1. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
[TBL] [Abstract][Full Text] [Related]
2. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
Chen RF; Li ZH; Zou SQ; Chen JS
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
[TBL] [Abstract][Full Text] [Related]
5. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
Wang SH; Liu NH; Wang J; Bai H; Mao L
Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
[TBL] [Abstract][Full Text] [Related]
6. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
9. Expression of nuclear factor kappa B in hepatitis C virus core gene transfected cholangiocarcinoma cells.
Liu X; Zou S; Qiu F
Chin Med J (Engl); 2002 Jul; 115(7):998-1001. PubMed ID: 12150729
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
Li T; Li D; Cheng L; Wu H; Gao Z; Liu Z; Jiang W; Gao YH; Tian F; Zhao L; Wang S
Ann Surg Oncol; 2010 Jul; 17(7):1937-44. PubMed ID: 20162464
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.
Zeng B; Li Z; Chen R; Guo N; Zhou J; Zhou Q; Lin Q; Cheng D; Liao Q; Zheng L; Gong Y
FEBS Lett; 2012 Sep; 586(19):3271-8. PubMed ID: 22819820
[TBL] [Abstract][Full Text] [Related]
12. si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma.
Xiang J; Luo F; Chen Y; Zhu F; Wang J
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):181-9. PubMed ID: 24361215
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
Yang B; House MG; Guo M; Herman JG; Clark DP
Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
[TBL] [Abstract][Full Text] [Related]
14. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
15. Role of epigenetic alterations in cholangiocarcinoma.
Tischoff I; Wittekind C; Tannapfel A
J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
[TBL] [Abstract][Full Text] [Related]
19. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.
Chen YJ; Tang QB; Zou SQ
World J Gastroenterol; 2005 Mar; 11(9):1333-8. PubMed ID: 15761971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]